the rise of b-cell therapies in relapsing ms
Published 3 years ago • 736 plays • Length 1:03:27Download video MP4
Download video MP3
Similar videos
-
26:57
b-cell therapies in relapsing ms: clarifying the options in an expanding treatment landscape
-
32:35
targeting btk in the treatment of patients with ms
-
1:00:54
re-examining s1pr modulation from all angles in relapsing multiple sclerosis
-
48:33
btk inhibitors for ms: progress in the development of an emerging therapeutic approach
-
50:02
exploring the rationale, results, and real-world clinical potential of btki in the management of ms
-
32:36
btk inhibition and the future of ms management
-
45:02
clinical implications of late-breaking data on disease modifying therapies for ms management
-
1:04:22
realizing the potential of s1p receptor modulation to improve outcomes in patients with ms
-
40:44
harnessing the full potential of dmt mechanisms of action to improve ms outcomes
-
2:56
moa of b cell therapy in ms
-
22:36
progress with btk inhibitors: a journey through the mechanisms of covalent and noncovalent options
-
52:31
rationale, evidence, and practical potential for btk inhibitors in patient-centered ms care
-
4:41
ofatumumab for relapsing ms
-
58:40
innovations and imaging in ms: examining the evidence, looking toward the future of btk inhibitors
-
1:03:01
drs. bar-or & traboulsee discuss #ms at #cmsc2023 - https://bit.ly/41u0vga
-
32:07
addressing barriers to the ready recognition and timely treatment of pediatric multiple sclerosis
-
1:28:55
expert tips for using car t-cell therapy in leukemia, lymphoma, and multiple myeloma care
-
38:37
ms treatment decisions before, during, and after pregnancy
-
45:35
btk inhibition as an ms treatment modality: where do we stand and where are we headed?